Literature DB >> 4069309

Enkephalin binding systems in human plasma. II: Leu-enkephalin serum albumin interaction.

V De Marco, R Possenti, F Vita, B Rapposelli, M D'Alagni, L G Roda.   

Abstract

Enkephalins are released into the bloodstream of mammals by the adrenal medulla. Once they are in the blood, these peptides undergo a fairly rapid hydrolysis by several plasma-contained enzymes. However, a fraction of the enkephalins present in the plasma are bound to the serum albumin, and the bound peptides are almost completely intact even after a long incubation in the presence of serum enzymes. Therefore, it seems possible that the interaction with serum albumin can maintain the functional integrity of the circulating enkephalins. Moreover, serum albumins are extremely well characterized proteins and, therefore, a suitable model for the study of protein-enkephalin interaction in general. The present work is a first step in the study of the mechanism of serum albumin-enkephalin interaction. Apparently, ionic parameters are important in the binding phenomenon. Furthermore, the serum albumin conformational status seems to be relevant in the binding. Finally, the binding is followed by a limited rearrangement of the protein molecule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4069309     DOI: 10.1007/BF00964978

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  18 in total

1.  Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine.

Authors:  J Hughes
Journal:  Brain Res       Date:  1975-05-02       Impact factor: 3.252

2.  Complete amino acid sequence of human serum albumin.

Authors:  B Meloun; L Morávek; V Kostka
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

3.  Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates.

Authors:  J M Hambrook; B A Morgan; M J Rance; C F Smith
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

4.  Extremely rapid degradation of [3H] methionine-enkephalin by various rat tissues in vivo and in vitro.

Authors:  A Dupont; L Cusan; M Garon; G Alvarado-Urbina; F Labrie
Journal:  Life Sci       Date:  1977-10-01       Impact factor: 5.037

5.  Serum albumin domain secondary structure prediction.

Authors:  A D McLachlan; J E Walker
Journal:  Biochim Biophys Acta       Date:  1978-09-26

6.  Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamines.

Authors:  O H Viveros; E J Diliberto; E Hazum; K J Chang
Journal:  Mol Pharmacol       Date:  1979-11       Impact factor: 4.436

7.  An 18,200-dalton adrenal protein that contains four [Met]enkephalin sequences.

Authors:  D L Kilpatrick; B N Jones; R V Lewis; A S Stern; K Kojima; J E Shively; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Enkephalin-binding systems in human plasma.

Authors:  R Possenti; V De Marco; O Cherubini; L G Roda
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

9.  Met-enkephalin circulates in human plasma.

Authors:  V Clement-Jones; P J Lowry; L H Rees; G M Besser
Journal:  Nature       Date:  1980-01-17       Impact factor: 49.962

10.  In vitro interaction of enkephalin with serum and chromaffin granule components.

Authors:  R Hogue-Angeletti; L G Roda
Journal:  Experientia       Date:  1980-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.